News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Parker Geoffrey M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2023 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
| 05/19/2023 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 7,778 shares
@ $32.86, valued at
$255.6k
Paid exercise price by delivering 3,734 shares
@ $32.86, valued at
$122.7k
Exercised 7,778 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Bought 5,000 shares
@ $38.054, valued at
$190.3k
|
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $1.4473, valued at
$36.2k
|
|
| 06/10/2022 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.66, valued at
$24.9k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 6,599 shares
@ $38.57, valued at
$254.5k
Paid exercise price by delivering 3,168 shares
@ $38.57, valued at
$122.2k
Granted 7,778 restricted stock units
@ $0
Exercised 6,599 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $2.1487, valued at
$32.2k
|
|
| 03/02/2022 |
4
| Parker Geoffrey M. (COO, CFO and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 256,000 options to buy
@ $7.96, valued at
$2M
|
|
| 01/04/2022 |
4
| Parker Geoffrey M. (COO, CFO and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Paid exercise price by delivering 1,384 shares
@ $9.56, valued at
$13.2k
|
|
| 12/17/2021 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Bought 5,000 shares
@ $36.854, valued at
$184.3k
|
|
| 12/16/2021 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $4.94, valued at
$98.8k
|
|
| 11/17/2021 |
4
| Parker Geoffrey M. (COO, CFO and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 166,667 shares
@ $6, valued at
$1M
Granted 166,667 options to buy
@ $11, valued at
$1.8M
|
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Parker Geoffrey M. (CFO and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 216,000 options to buy
@ $7.03, valued at
$1.5M
|
|
| 12/10/2020 |
4
| Parker Geoffrey M. (CFO and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 15,000 shares
@ $6.78, valued at
$101.7k
|
|
| 09/14/2020 |
4
| Parker Geoffrey M. (Chief Fin. Officer and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 4,000 shares
@ $0 |
|
| 05/26/2020 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 2,888 options to buy
@ $59.73, valued at
$172.5k
Granted 4,660 restricted stock units
@ $0
Exercised 7,724 restricted stock units
@ $0 |
|
| 05/19/2020 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 6,054 shares
@ $52.76, valued at
$319.4k
Paid exercise price by delivering 2,906 shares
@ $52.76, valued at
$153.3k
Exercised 6,054 restricted stock units
@ $0 |
|
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2020 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 3,199 shares
@ $34.4316, valued at
$110.1k
Sold 2,801 shares
@ $35.3201, valued at
$98.9k
Sold 9,181 shares
@ $36.7171, valued at
$337.1k
Sold 13,959 shares
@ $37.3958, valued at
$522k
Sold 860 shares
@ $38.2128, valued at
$32.9k
|
|
| 03/11/2020 |
4
| Parker Geoffrey M. (Chief Fin. Officer and EVP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 5,000 shares
@ $29.46, valued at
$147.3k
|
|
| 02/26/2020 |
4
| Parker Geoffrey M. (Chief Fin. Officer and Sr. VP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Granted 130,000 options to buy
@ $35.12, valued at
$4.6M
|
|
| 12/04/2019 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Exercised 31,990 options to buy
@ $6, valued at
$191.9k
|
|
| 11/19/2019 |
4
| Parker Geoffrey M. (Chief Fin. Officer and Sr. VP) has filed a Form 4 on Tricida, Inc.|
Txns:
| Bought 19,055 shares
@ $34.28, valued at
$653.2k
Bought 945 shares
@ $34.72, valued at
$32.8k
|
|
|
|
|